Evidence map›Paper›PMID 42753315›Full record

ArticleRedox biology2026

Resistance to atrial fibrillation domestication and mitochondrial dysfunction in sheep: a potential key role of the TCA cycle and mitochondrial redox state.

Guido Caluori, Stanley Nattel, Benoît Pinson, Patrice Naud, Bertrand Beauvoit, Stéphane Claverol, Fanny Vaillant, Sabine Charron, Florent Guilloteau, Virginie Loyer and 15 more

Abstract read
In one paragraph

Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Guido CaluoriUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Stanley NattelDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Québec, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada; Institute of Pharmacology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
Benoît PinsonService d'Analyses Métaboliques- TBMCore, CNRS UAR 3427, Inserm US 005, Univ. Bordeaux, France; Univ. Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, F-33000, France.
Patrice NaudDepartment of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Québec, Canada; Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada; Institute of Pharmacology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
Bertrand BeauvoitUniv. Bordeaux, INRAE, BFP, UMR 1332, Villenave d'Ornon, F-33140, France.
Stéphane ClaverolPlateforme Protéome, Univ. Bordeaux, Bordeaux, France.
Fanny VaillantUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Sabine CharronUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Florent GuilloteauLaboratoire de diagnostic moléculaire, hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.
Virginie LoyerUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Marion ConstantinUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Miruna PopaUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Andrei BelykhUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Anaïs RogowskyUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Andreas HaeberlinUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Sylvain PlouxUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France; CHU de Bordeaux, INSERM, U 1045, Bordeaux, F-33000, France.
Hassan Adam MahamatUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Rémi DuboisUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Bastien GuillotUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Philipp KrisaiUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Tsukasa KamakuraUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Olivier BernusUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France.
Pierre JaïsUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France; CHU de Bordeaux, INSERM, U 1045, Bordeaux, F-33000, France.
Pierre Dos SantosUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France; CHU de Bordeaux, INSERM, U 1045, Bordeaux, F-33000, France.
Philippe PasdoisUniv. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, F-33000, France; Univ. Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, F-33000, France. Electronic address: philippe.pasdois@u-bordeaux.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) often progresses from paroxysmal to more stable forms. It is well-recognized that patients vary in their AF progression, but the underlying mechanisms remain unclear. This work, performed in a sheep AF-model, aimed to identify atrial redox and energetic status differences between animals developing stable AF (AF-S) versus those resistant to AF-stabilization (AF-R).

methodsAF was induced with bursts of atrial tachystimulation, maintained whenever sinus rhythm resumed, and monitored with telemetry. Electrophysiological and structural remodeling were assessed via contact mapping, and histology, respectively. Proteomic, metabolomic, enzymatic, and bioenergetic remodeling were evaluated using left atrial appendage (LAA) tissues and isolated LAA mitochondria. Healthy rats were used to investigate whether a metabolic challenge stabilizes electrically induced AF episodes.

resultsAF-S (N = 12) sheep developed stable AF after 13 days on average, whereas AF-R (N = 8) sheep failed to develop self-sustained AF despite 120 days of tachypacing. Contact mapping and histological analysis revealed that AF-S animals presented reduced atrial conduction velocity, and increased endomysial fibrosis. Metabolic analysis showed significant differences in tricarboxylic acid cycle (TCA) enzymes activities and a 45% succinate content increase in AF-S LAA versus AF-R. AF-S mitochondria showed abnormal succinate oxidation, decreased ATP synthesis rate, and increased ROS emission. The ratios of ATP/ADP, NAD

conclusionsAF-S sheep showed TCA cycle, energetic and redox adaptations compared to AF-R. In this animal model, TCA cycle remodeling and associated redox and energetic responses determined the resistance to AF domestication, with potential relevance to identify new mechanistic determinants of AF progression in humans.

Indexed as

Atrial FibrillationCitric Acid CycleMitochondriaMitochondria, HeartAnimalsDisease Models, AnimalEnergy MetabolismFemaleOxidation-ReductionRatsSheepAtrial fibrillationLarge animal modelsMitochondriaSuccinateTCA cycle

Identifiers

PMID42753315
PMCPMC13602041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.